Precise targeting of HIV broadly neutralizing antibody precursors in humans | Science
A protective HIV vaccine will need to induce broadly neutralizing antibodies (bnAbs) in humans, but priming rare bnAb precursor B cells has been challenging. In a double-blinded, placebo-controlled phase 1 human clinical trial, the recombinant, germline...Read More
bubmagMay 15, 2025